DESPITE OUR EXTENSIVE UNDERSTANDING of the typical responses and adaptations to an exercise stimulus, we are often left scratching our heads about outliers: what explains those subjects who fall at the tails of the normal curve? Why do some individuals show remarkable gains while others, who are working equally hard, fall so far short, potentially even showing adverse responses? This issue has challenged exercise scientists for years (1) but has only recently been addressed in earnest with the expansion of genomic studies, which seek to identify the unique individual (and, presumably, genetic) factors underlying these thus far unpredictable responses (12). Despite considerable effort, these purely genomic investigations have made limited progress, with only a handful of genes that can be called "solid" as contributors to exercise-related traits and fewer yet (if any) reaching the level of "predictive" (9), which is ultimately the goal as we strive toward personalized (exercise) medicine (10). That few genomic factors have been clearly identified, despite years of effort, points to several limitations in the emerging field of exercise genomics: 1) few large-scale studies are available for pursuit of complex analyses; 2) recent findings point to the very real possibility that many genes of small effect contribute to complex traits, making their identification exceedingly difficult; and 3) we may simply be looking in the wrong places: looking for lost keys under the light post is the easiest starting place, although it is not always the best place to look. The genome is a vast landscape of Ͼ3 ϫ 10 9 letters, the sequence of which is known but the function of which is still largely hidden from our understanding. Are we simply looking in the wrong places? Are we too "gene-centric" in our approach to explaining responders and nonresponders?
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In this issue of the Journal of Applied Physiology, Davidsen and colleagues (2) provide strong evidence that we exercisegene hunters will need to broaden considerably our search within the genomic landscape for predictive targets. Instead of focusing on typical genetic variation approaches (e.g., polymorphisms), the authors targeted differences in microRNA (miRNA) expression between responders and nonresponders to a strength-training program. miRNAs are small noncoding RNA species that bind to mRNA species, generally resulting in posttranscriptional gene silencing (4) . Each of the hundreds of known miRNAs can bind to many mRNA targets, making this one of the most complex gene regulatory processes. Several groups have recently shown the potential importance of miRNA regulation in exercise adaptations in skeletal muscle, showing this as fertile ground for investigation. For example, miRNAs have been found to be responsive to aerobic exercise training and detraining in humans (7) and to functional overload (6) and endurance exercise (11) in mouse models.
In the study of Davidsen et al. (2) , vastus lateralis biopsies were taken from the top and bottom (high and low, respectively) responders among 56 men who completed a 12-wk strength-training program, with 21 miRNA targets selected a priori on the basis of their high expression in skeletal muscle. Although most of the miRNA targets were unresponsive to exercise or showed similar profiles across the high-and lowresponder groups, four miRNAs showed uniquely different signatures between groups. Three of the miRNAs (miR-378, miR-29a, and miR-26a) were downregulated in low responders and unchanged in high responders, while the fourth, miR-451, was upregulated only in the low responders. In the case of miR-378, the level of expression was positively correlated with muscle mass gains across the entire group of men (see Fig. 3 in Ref.
2). Davidson et al. went on to perform a gene ontology analysis to gain insights into the possible role of these miRNAs in skeletal muscle biology by identifying possible interacting factors and targets. Although some expected pathways were identified in this analysis (e.g., mammalian target of rapamycin and focal adhesion kinase), the authors mostly saw an immense set of gene families for which these miRNAs could play a regulatory role, thus generating more questions than answers. This sort of gene ontology analysis is limited by our inadequate knowledge of the complexity of skeletal muscle biology and, moreover, by the incomplete understanding of the breadth of binding targets of these particular miRNAs. Nonetheless, this type of systems biology bioinformatic analysis will be necessary to eventually address the breadth of interacting factors in complex biological systems, such as skeletal muscle adaptation, and identify predictable patterns within those systems that can be exploited for personalized prescription. The authors have approached the issue of responders and nonresponders in a unique way and provide a model for future investigations.
The findings of Davidsen et al. (2) are novel and will certainly be scrutinized; we can argue about the rationale for the chosen miRNAs, the influence of the diet intervention in explaining the differential muscle responses, and the sample size. Certainly, replication is required to gain insight into the consistency and strength of these findings across related exercise stimuli. Despite these minor limitations, the authors have put forth evidence of a unique contribution of miRNAs, not only to skeletal muscle adaptation to strength training in humans, but also to partially explaining the broad interindividual variability in those adaptations.
The need to broaden our perspective on how to explain responders and nonresponders has been argued previously. Bamman and co-workers (8) found evidence that interindividual differences in satellite cell populations and recruitment into the myonuclear pool contribute to differential myofiber hypertrophy. Timmons and colleagues (13) recently published an elegant study demonstrating the power of combining transcriptomic and genome variation approaches to identifying genetic predictors underlying cardiorespiratory responses to aerobic exercise training. In a unique investigation of transcriptomes (including miRNAs) in humans and rodents, Keller et al. (5) showed the power of comparative strategies in identifying mechanisms of exercise adaptation, which can certainly be exploited for understanding the responder-nonresponder issue. Recent advances in understanding human genome biology will improve our ability to perform genomic investigations (3), but the full breadth of systems biology approaches (i.e., combining multiple -omics technologies) in appropriately powered intervention studies will be necessary to fully understand the complexity of gene-gene and gene-environment interactions that underlie interindividual variation.
Davidsen and colleagues (2) are not the first to argue for the importance of miRNA to exercise adaptations, but their group is the first to show the potential importance of this aspect of genomics for explaining variability in strength-training adaptations. How these miRNAs are themselves regulated and how those underlying factors can be exploited for individual prediction relevant to genomic medicine (in particular, without requiring the muscle biopsy!) remain to be seen. Theirs is an important first step nonetheless; without first providing evidence that the genome's dark places have importance, many of us would still be looking under the light posts, rather than venturing to illuminate and explore this larger and potentially more fruitful area of the genome.
